Company:  AIT THERAPEUTICS, INC. (AITB)
Form Type:  S-1/A
Filing Date:  5/19/2017 
CIK:  0001641631 
Address:  500 MAMARONECK AVENUE, SUITE 320 
City, State, Zip:  HARRISON, New York 10528 
Telephone:  516-665-8200 
Fiscal Year:  06/30 
Last Trade
Last Trade: 
$3.00  
Change: 
0.02 (0.67%)  
Trade Time: 
May 25  
Market Cap: 
$25.19M
Trade AITB now with 

© 2018  
Description of Business
We are an emerging medical device company developing a nitric oxide (NO) delivery system, or the AIT NO Delivery System, that is capable of generating NO from ambient air. The AIT NO Delivery System can generate up to 400 parts per million (ppm) for delivery to a patient's lung. The AIT NO Delivery System can deliver NO either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. We believe that there is a high unmet medical need for patients suffering from certain severe lung infections for which our system can be used. Our current product candidates, if approved, will be marketed as medical devices and will be subject to premarket reviews and approvals by the U.S. Food and Drug Administration, or the FDA.
Register and access this filing in:     
  FORM S-1/A
    CALCULATION OF REGISTRATION FEE
    Subject to Completion, dated May 19, 2017
    TABLE OF CONTENTS
    SUMMARY
      Competition
    The Offering
    RISK FACTORS
    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    COMMON STOCK PRICE RANGE AND DIVIDENDS
    CAPITALIZATION
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ...
      Operating Expenses
      Liquidity and Capital Resources
    BUSINESS
    SECURITY OWNERSHIP OF
      BENEFICIAL OWNERS
    SELLING STOCKHOLDERS
      BENEFICIAL OWNERS
    MANAGEMENT
      NAME AND TITLE
      Involvement in Certain Legal Proceedings
    Compensation of Executive Officers and Directors
      COMPENSATION TABLE
    Director Compensation
    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
    Review, Approval or Ratification of Transactions with ...
    DESCRIPTION OF SECURITIES
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
      BALANCE SHEET
      BALANCE SHEET
      STOCKHOLDERS EQUITY
      CASH FLOW
      NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
      OPTIONS
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
      Item 13. Other Expenses of Issuance and Distribution.
      Item 14. Indemnification of Directors and Officers.
      Item 15. Recent Sales of Unregistered Securities
      Item 16. Exhibits
      Item 17. Undertakings
    SIGNATURES
    POWER OF ATTORNEY